Austin W. Marxe & David M. Greenhouse’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$17.4M Sell
180,000
-20,000
-10% -$1.95M 2.38% 7
2014
Q2
$18.4M Hold
200,000
2.33% 8
2014
Q1
$14M Sell
200,000
-91,095
-31% -$6.2M 1.55% 17
2013
Q4
$16.7M Sell
291,095
-50,044
-15% -$2.63M 1.79% 15
2013
Q3
$16.4M Sell
341,139
-158,690
-32% -$5.78M 2.01% 10
2013
Q2
$14.5M Buy
+499,829
New +$14.5M 1.95% 10

Other funds holding PCRX

Austin W. Marxe & David M. Greenhouse's PCRX Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse reduced its Pacira BioSciences (PCRX) stake by 10% in Q3 2014, selling an estimated $1.95M and leaving 180,000 shares worth $17.4M. The position accounts for 2.38% of the portfolio, ranked #7.

Austin W. Marxe & David M. Greenhouse first reported a position in PCRX in Q2 2013 and has held it in 6 quarters since. The position peaked at $18.4M in Q2 2014. 208 funds tracked by Wall St. Rank hold PCRX as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 180,000 shares of Pacira BioSciences worth $17.4M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse sold 20,000 Pacira BioSciences shares in Q3 2014, an estimated $1.95M.
  • Pacira BioSciences made up 2.38% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #7 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Pacira BioSciences in Q2 2013 and has held it in 6 quarters since.
  • Austin W. Marxe & David M. Greenhouse's Pacira BioSciences position peaked at $18.4M in Q2 2014.
  • 208 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.